BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR, Clarke CL. Expression of Progesterone Receptor A and B Isoforms in Low-grade Endometrial Stromal Sarcoma: . International Journal of Gynecological Pathology 2004;23:138-44. [DOI: 10.1097/00004347-200404000-00008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Nasioudis D, Ko EM, Kolovos G, Vagios S, Kalliouris D, Giuntoli RL. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis. Int J Gynecol Cancer 2019;29:126-32. [PMID: 30640694 DOI: 10.1136/ijgc-2018-000063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
4 Nieves-Neira W, Kim JJ, Matei D. Hormonal strategies in gynecologic cancer: Bridging biology and therapy. Gynecol Oncol 2018;150:207-10. [PMID: 29933928 DOI: 10.1016/j.ygyno.2018.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Park J, Baek M, Park Y, Kim Y, Nam J. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma. Virchows Arch 2018;473:61-9. [DOI: 10.1007/s00428-018-2358-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
6 Deshmukh U, Black J, Perez-irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi D, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reprod Sci 2018;26:600-8. [DOI: 10.1177/1933719118778801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Köhler G, Zygmunt MT. Uterine Sarcomas and Atypical Smooth-Muscle Tumors: Clinic, Diagnostics and Appropriate Surgical Therapy. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_14] [Reference Citation Analysis]
8 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
9 Ahn JI, Yoo JY, Kim TH, Kim YI, Ferguson SD, Fazleabas AT, Young SL, Lessey BA, Ahn JY, Lim JM, Jeong JW. cAMP-Response Element-Binding 3-Like Protein 1 (CREB3L1) is Required for Decidualization and its Expression is Decreased in Women with Endometriosis. Curr Mol Med 2016;16:276-87. [PMID: 26917262 DOI: 10.2174/1566524016666160225153659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ryu H, Choi YS, Song IC, Yun HJ, Jo DY, Kim S, Lee HJ. Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: A report of two cases and a review of the literature. Oncol Lett 2015;10:3310-4. [PMID: 26722331 DOI: 10.3892/ol.2015.3674] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
11 Baker PM, Oliva E. Prognostic Factors in Uterine Cancer. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_4] [Reference Citation Analysis]
12 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
13 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
14 D'Angelo E, Prat J. Diagnostic use of immunohistochemistry in uterine mesenchymal tumors. Semin Diagn Pathol 2014;31:216-22. [PMID: 24863031 DOI: 10.1053/j.semdp.2014.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
15 Kimble T, Thurman A, Schwartz J. Currently available combined oral contraception. Expert Review of Obstetrics & Gynecology 2014;6:525-38. [DOI: 10.1586/eog.11.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124-37. [PMID: 23240674 DOI: 10.1111/his.12048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
17 Jakate K, Azimi F, Ali RH, Lee C, Clarke BA, Rasty G, Shaw PA, Melnyk N, Huntsman DG, Laframboise S, Rouzbahman M. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 2013;26:95-105. [DOI: 10.1038/modpathol.2012.136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
18 Large MJ, DeMayo FJ. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol Cell Endocrinol 2012;358:155-65. [PMID: 21821095 DOI: 10.1016/j.mce.2011.07.027] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 8.9] [Reference Citation Analysis]
19 Cheng X, Yang G, Schmeler KM, Coleman RL, Tu X, Liu J, Kavanagh JJ. Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy. Gynecol Oncol. 2011;121:323-327. [PMID: 21277011 DOI: 10.1016/j.ygyno.2010.12.360] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
20 Seddon BM, Davda R. Uterine sarcomas--recent progress and future challenges. Eur J Radiol 2011;78:30-40. [PMID: 21247711 DOI: 10.1016/j.ejrad.2010.12.057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
21 Pabona JM, Zeng Z, Simmen FA, Simmen RC. Functional differentiation of uterine stromal cells involves cross-regulation between bone morphogenetic protein 2 and Kruppel-like factor (KLF) family members KLF9 and KLF13. Endocrinology 2010;151:3396-406. [PMID: 20410205 DOI: 10.1210/en.2009-1370] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
22 Chew I, Oliva E. Endometrial stromal sarcomas: a review of potential prognostic factors. Adv Anat Pathol 2010;17:113-21. [PMID: 20179433 DOI: 10.1097/PAP.0b013e3181cfb7c2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
23 Lee CH, Ali R, Gilks CB. Molecular Genetics of Mesenchymal Tumors of the Female Genital Tract. Surg Pathol Clin 2009;2:823-34. [PMID: 26838781 DOI: 10.1016/j.path.2009.08.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer 2009;115:1867-74. [DOI: 10.1002/cncr.24197] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
25 Zagouri F, Dimopoulos AM, Fotiou S, Kouloulias V, Papadimitriou CA. Treatment of early uterine sarcomas: disentangling adjuvant modalities. World J Surg Oncol 2009;7:38. [PMID: 19356236 DOI: 10.1186/1477-7819-7-38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
26 Baker PM, Oliva E. Prognostic Factors in Uterine Cancer. Uterine Cancer 2009. [DOI: 10.1007/978-1-60327-044-1_6] [Reference Citation Analysis]
27 Kurihara S, Oda Y, Ohishi Y, Iwasa A, Takahira T, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M. Endometrial Stromal Sarcomas and Related High-grade Sarcomas: Immunohistochemical and Molecular Genetic Study of 31 Cases. American Journal of Surgical Pathology 2008;32:1228-38. [DOI: 10.1097/pas.0b013e31816a3b42] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 10.6] [Reference Citation Analysis]
28 Brown L. Pathology of uterine malignancies. Clin Oncol (R Coll Radiol) 2008;20:433-47. [PMID: 18499412 DOI: 10.1016/j.clon.2008.04.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
29 Alkasi Ö, Meinhold-heerlein I, Zaki R, Fasching P, Maass N, Jonat W, Beckmann MW. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report. Arch Gynecol Obstet 2009;279:57-60. [DOI: 10.1007/s00404-008-0631-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
30 Sandberg A. The cytogenetics and molecular biology of endometrial stromal sarcoma. Cytogenet Genome Res 2007;118:182-9. [DOI: 10.1159/000108299] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
31 Gadducci A, Cosio S, Romanini A, Genazzani AR. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65:129-142. [PMID: 17706430 DOI: 10.1016/j.critrevonc.2007.06.011] [Cited by in Crossref: 164] [Cited by in F6Publishing: 181] [Article Influence: 10.9] [Reference Citation Analysis]
32 Reich O, Regauer S. Hormonal therapy of endometrial stromal sarcoma. Current Opinion in Oncology 2007;19:347-52. [DOI: 10.1097/cco.0b013e3281a7ef3a] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 5.9] [Reference Citation Analysis]
33 Gao Z, Ouansafi I, Anderson AE. Endocervical stromal sarcoma. J Obstet Gynaecol 2006;26:832-5. [PMID: 17130058 DOI: 10.1080/01443610600994874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Li AJ, Giuntoli RL, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY. Ovarian Preservation in Stage I Low-Grade Endometrial Stromal Sarcomas: . Obstetrics & Gynecology 2005;106:1304-8. [DOI: 10.1097/01.aog.0000185511.91694.1e] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 4.5] [Reference Citation Analysis]